longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CRISPR Therap

CRSP

56.0452.23% ( -1.280 )
Trading: Sep 18, 12:27:08 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
Share your thoughts

What's on your mind?

0 / 2,000
  • M
    Michael Burry TrackerApr 8 at 05:12 PM

    Cathie Wood reads the Bible every morning. She named her $13 billion fund after the Ark of the Covenant

    At 58, she launched it after AllianceBernstein told her the idea was too risky. At 65, Bloomberg called her the best stock picker on earth. At 68, Morningstar called her the worst

    Meet the devout Christian who bet everything on what she believes to be the future

    Timeline:

    • Graduated USC summa cum laude in finance

    • Got her first job through Arthur Laffer at 22

    • Spent 18 years at Jennison Associates as chief economist

    • Joined AllianceBernstein in 2001, managed $5 billion

    • Pitched actively managed ETFs focused on disruptive innovation. They said no

    • Left and founded ARK Invest in 2014. Her first 4 ETFs were seeded by Bill Hwang, who went to jail for blowing up $36 billion at Archegos

    • 2020: ARKK more than doubled. Bloomberg named her best stock picker of the year

    • 2022: Morningstar named ARKK the worst-performing US equity fund in Q1

    • 2024: Morningstar ranked ARK the #1 wealth-destroying fund family of the decade. $14.3 billion gone

    • Today: still running $13 billion across all funds - all-in on Tesla, CRISPR, and AI

    Here's what ARK is buying now:

    $Tesla(TSLA.US) — Tesla, the EV and autonomous driving bet she's held since 2014. Down 20% YTD

    $CRISPR Therap(CRSP.US) — CRISPR Therapeutics, the gene-editing company rewriting human DNA. Down 4% YTD

    $Tempus AI(TEM.US) — Tempus AI, an AI-powered precision medicine company. Down 23% YTD

    $Shopify (SHOP.US) — Shopify, the platform powering millions of online stores. Down 22% YTD

    $Coinbase(COIN.US) — Coinbase, the crypto exchange she bought the dip on. Down 24% YTD

    Every top holding is red this year, yet she’s still buying

    图片 1,共 1 张
  • P
    ProfitJan 12 at 09:56 AM

    The recent biotech stock market is really a tale of two extremes. CRSP and NTLA in hand are still struggling, chasing the dream of gene editing but completely missing the big surge of MLTX and ELVN, watching RVMD hit new highs again, feeling really sour. The ability to tell stories in a bull market is still there, but it's just a matter of whether it's your turn. Every time I think I'm holding onto faith, it turns into internal friction.

  • B
    Boss's BossDec 5, 2025 at 04:16 AM

    RXRX 一周展望,By Grok

    $Recursion Pharmaceuticals(RXRX.US) Recursion Pharmaceuticals Inc.(RXRX)Weekly Report (2025.11.22-11.29) The extent of your achievements can largely be seen from how much pain you can endure...